- Publicações
- Pesquisar
- Estatísticas
Integrated Optimization of Retrovirus Production for Gene Therapy
AuthID
P-001-5BJ
P-001-5BJ
5
Author(s)
4
Editor(es)
Bernard, A; Griffiths, B; Noe, W; Wurm, F
Tipo de Documento
Proceedings Paper
Year published
1999
Publicado
in ANIMAL CELL TECHNOLOGY: PRODUCTS FROM CELLS, CELLS AS PRODUCTS
Páginas: 413-+ (7)
Conference
16Th Meeting of the European-Society-For-Animal-Cell-Technology (Esact), Date: APR 25-29, 1999, Location: LUGANO, SWITZERLAND, Patrocinadores: Akzo Nobel Pharma, Amersham Pharmacia Biotech, Ares Serono SA, B Braun Biotech Int GmbH, Bayer Corp, Bioengn AG, BioWhittaker Inc, Boehringer Ingelheim Pharm KG, BioInvent Prod AB, Canberra Packard SA, Cansera Int Inc, Cantone Ticino, Crossair Swissair, E Merck, Genentech Inc, Genet Inst, Genzyme Transgen Corp, Hoffmann La Roche AG, Hyclone Europe SA, Immuno AG, Div Baxter Inc, Immunex Corp, Inst Rech Pierre Fabre, Intervet Int BV, Inveresk Res Int Ltd, JRH Biosci, Life Technologies Ltd, Lonza Biol Plc, MA Bioserv, Merck Res Labs, MicroSafe BV, Novartis Pharma AG, Novo Nordisk AS, Nunc AS, Pall Europe Ltd, Pasteur Merieux Connaught, PCS Process Control Syst AG, Pharmacia & Upjohn AB, Q One Biotech Ltd, Sanofi Rech, Scharfe Syst GmbH, Schering AG, Swiss Red Cross, ZLB, SmithKline Beecham Biol, Union Bank Switzerland
Indexing
Publication Identifiers
Wos: WOS:000085945800088
Export Publication Metadata
Publication Export Settings
Lista Marked
Info
At this moment we don't have any links to full text documens.